In many cases of DMD, the dystrophin protein is not expressed at all, while, in SMA patients, the SMN protein is produced, albeit in small amounts, from the dysfunctional SMN2 gene. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.